| Year |
Citation |
Score |
| 2020 |
Shariff-Marco S, Canchola AJ, Keegan THM, Nickell A, Oakley-Girvan I, Hamilton AS, Gomez SL. Abstract B039: The impact of social and built environments on quality of life among cancer survivors Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-B039 |
0.315 |
|
| 2019 |
Rehkopf DH, Rodriguez D, Cress R, Braithwaite D, Oakley-Girvan I, West D, Hiatt RA. Socioeconomic gradients in cancer incidence by race and ethnicity in California, 2008-2012: the influence of tobacco use or screening detectable cancers. Cancer Causes & Control : Ccc. PMID 31065915 DOI: 10.1007/S10552-019-01172-4 |
0.421 |
|
| 2019 |
Gong G, Wang W, Hsieh CL, Van Den Berg DJ, Haiman C, Oakley-Girvan I, Whittemore AS. Data-adaptive multi-locus association testing in subjects with arbitrary genealogical relationships. Statistical Applications in Genetics and Molecular Biology. PMID 30956231 DOI: 10.1515/Sagmb-2018-0030 |
0.554 |
|
| 2018 |
Liu GS, Cook A, Richardson M, Vail D, Holsinger FC, Oakley-Girvan I. Thyroid cancer risk in airline cockpit and cabin crew: a meta-analysis. Cancers of the Head & Neck. 3: 7. PMID 31093360 DOI: 10.1186/S41199-018-0034-8 |
0.399 |
|
| 2018 |
Scarton LA, Del Fiol G, Oakley-Girvan I, Gibson B, Logan R, Workman TE. Understanding cancer survivors' information needs and information-seeking behaviors for complementary and alternative medicine from short- to long-term survival: a mixed-methods study. Journal of the Medical Library Association : Jmla. 106: 87-97. PMID 29339938 DOI: 10.5195/Jmla.2018.200 |
0.325 |
|
| 2017 |
Oakley-Girvan I, Davis SW. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review. Cancer Biomarkers : Section a of Disease Markers. PMID 29060925 DOI: 10.3233/Cbm-170177 |
0.328 |
|
| 2017 |
Davis SW, Oakley-Girvan I. Achieving value in mobile health applications for cancer survivors. Journal of Cancer Survivorship : Research and Practice. PMID 28342093 DOI: 10.1007/S11764-017-0608-1 |
0.402 |
|
| 2016 |
Divi V, Tao L, Whittemore A, Oakley-Girvan I. Geographic variation in Medicare treatment costs and outcomes for advanced head and neck cancer. Oral Oncology. 61: 83-8. PMID 27688109 DOI: 10.1016/J.Oraloncology.2016.08.018 |
0.5 |
|
| 2016 |
Divi V, Tao L, Whittemore A, Oakley-Girvan I. Geographic Variation in the Costs and Outcomes of Treatment for Head and Neck Cancer International Journal of Radiation Oncology*Biology*Physics. 94: 913. DOI: 10.1016/J.Ijrobp.2015.12.144 |
0.572 |
|
| 2015 |
Clarke CA, Reynolds P, Oakley-Girvan I, Lee E, Lu Y, Yang J, Moy LM, Bernstein L, Horn-Ross PL. Indicators of microbial-rich environments and the development of papillary thyroid cancer in the California Teachers Study. Cancer Epidemiology. PMID 26007306 DOI: 10.1016/J.Canep.2015.04.014 |
0.381 |
|
| 2015 |
Davis SW, Oakley-Girvan I. mHealth Education Applications Along the Cancer Continuum. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 30: 388-94. PMID 25482319 DOI: 10.1007/S13187-014-0761-4 |
0.395 |
|
| 2014 |
Palmer NR, Kent EE, Forsythe LP, Arora NK, Rowland JH, Aziz NM, Blanch-Hartigan D, Oakley-Girvan I, Hamilton AS, Weaver KE. Racial and ethnic disparities in patient-provider communication, quality-of-care ratings, and patient activation among long-term cancer survivors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 4087-94. PMID 25403220 DOI: 10.1200/Jco.2014.55.5060 |
0.346 |
|
| 2014 |
Horn-Ross PL, Lichtensztajn DY, Clarke CA, Dosiou C, Oakley-Girvan I, Reynolds P, Gomez SL, Nelson DO. Continued rapid increase in thyroid cancer incidence in california: trends by patient, tumor, and neighborhood characteristics. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1067-79. PMID 24842625 DOI: 10.1158/1055-9965.Epi-13-1089 |
0.366 |
|
| 2014 |
Teerlink CC, Thibodeau SN, McDonnell SK, Schaid DJ, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, ... ... Oakley-Girvan I, et al. Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease. Human Genetics. 133: 347-56. PMID 24162621 DOI: 10.1007/S00439-013-1384-2 |
0.684 |
|
| 2014 |
Kent EE, Mitchell SA, Oakley-Girvan I, Arora NK. The importance of symptom surveillance during follow-up care of leukemia, bladder, and colorectal cancer survivors. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 22: 163-72. PMID 24018909 DOI: 10.1007/S00520-013-1961-X |
0.322 |
|
| 2013 |
Weaver KE, Foraker RE, Alfano CM, Rowland JH, Arora NK, Bellizzi KM, Hamilton AS, Oakley-Girvan I, Keel G, Aziz NM. Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? Journal of Cancer Survivorship : Research and Practice. 7: 253-61. PMID 23417882 DOI: 10.1007/S11764-013-0267-9 |
0.459 |
|
| 2013 |
Chawla N, Arora N, Oakley-Girvan I, Clauser S. PS1-38: Colorectal Cancer Survivors' Trust in Their Follow-Up Care Physician: The Role of Patient-Physician Communication by Stage of Cancer Clinical Medicine & Research. 11: 130-130. DOI: 10.3121/Cmr.2013.1176.Ps1-38 |
0.406 |
|
| 2012 |
Kent EE, Arora NK, Rowland JH, Bellizzi KM, Forsythe LP, Hamilton AS, Oakley-Girvan I, Beckjord EB, Aziz NM. Health information needs and health-related quality of life in a diverse population of long-term cancer survivors. Patient Education and Counseling. 89: 345-52. PMID 23021856 DOI: 10.1016/J.Pec.2012.08.014 |
0.324 |
|
| 2012 |
Bellizzi KM, Aziz NM, Rowland JH, Weaver K, Arora NK, Hamilton AS, Oakley-Girvan I, Keel G. Double Jeopardy? Age, Race, and HRQOL in Older Adults with Cancer. Journal of Cancer Epidemiology. 2012: 478642. PMID 22888348 DOI: 10.1155/2012/478642 |
0.429 |
|
| 2012 |
Bailey-Wilson JE, Childs EJ, Cropp CD, Schaid DJ, Xu J, Camp NJ, Cannon-Albright LA, Farnham JM, George A, Powell I, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, ... ... Oakley-Girvan I, et al. Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families. Bmc Medical Genetics. 13: 46. PMID 22712434 DOI: 10.1186/1471-2350-13-46 |
0.648 |
|
| 2012 |
Jin G, Lu L, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Cannon-Albright LA, Camp NJ, Teerlink CC, Fitzgerald LM, Stanford JL, Wiley KE, Isaacs SD, Walsh PC, Foulkes WD, ... ... Oakley-Girvan I, et al. Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG). Human Genetics. 131: 1095-103. PMID 22198737 DOI: 10.1007/S00439-011-1136-0 |
0.647 |
|
| 2012 |
Lu L, Cancel-Tassin G, Valeri A, Cussenot O, Lange EM, Cooney KA, Farnham JM, Camp NJ, Cannon-Albright LA, Tammela TL, Schleutker J, Hoegel J, Herkommer K, Maier C, Vogel W, ... ... Oakley-Girvan I, et al. Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG. The Prostate. 72: 410-26. PMID 21748754 DOI: 10.1002/Pros.21443 |
0.625 |
|
| 2012 |
Bloom JR, Stewart SL, Oakley-Girvan I, Banks PJ, Shema S. Quality of life of younger breast cancer survivors: persistence of problems and sense of well-being. Psycho-Oncology. 21: 655-65. PMID 21538677 DOI: 10.1002/Pon.1965 |
0.302 |
|
| 2012 |
McDermott CL, Blough DK, Fedorenko CR, Arora NK, Zeliadt SB, Fairweather ME, Oakley-Girvan I, Van Den Eeden SK, Ramsey SD. Complementary and alternative medicine use among newly diagnosed prostate cancer patients. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 20: 65-73. PMID 21120540 DOI: 10.1007/S00520-010-1055-Y |
0.494 |
|
| 2012 |
Oakley-Girvan I. Family history, perceived risk, and prostate cancer screening among African American men (Cancer Epidemiology, Biomarkers and Prevention (2006) 15, (2167-2173)) Cancer Epidemiology Biomarkers and Prevention. 21: 388. DOI: 10.1158/1055-9965.EPI-11-1118 |
0.473 |
|
| 2011 |
Arora NK, Reeve BB, Hays RD, Clauser SB, Oakley-Girvan I. Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1280-9. PMID 21357781 DOI: 10.1200/Jco.2010.32.1554 |
0.363 |
|
| 2011 |
Kent EE, Arora NK, Bellizzi KM, Aziz NM, Hamilton AS, Oakley-Girvan I, Rowland JH. Abstract A53: Disparities in health information needs among long-term cancer survivors Cancer Epidemiology, Biomarkers & Prevention. 20. DOI: 10.1158/1055-9965.Disp-11-A53 |
0.38 |
|
| 2010 |
Ramsey SD, Zeliadt SB, Arora NK, Blough DK, Penson DF, Oakley-Girvan I, Hamilton AS, Van Den Eeden SK, Fedorenko CR, Potosky AL. Unanticipated and underappreciated outcomes during management of local stage prostate cancer: a prospective survey. The Journal of Urology. 184: 120-5. PMID 20478590 DOI: 10.1016/J.Juro.2010.03.023 |
0.456 |
|
| 2010 |
Christensen GB, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, ... ... Oakley-Girvan I, et al. Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. The Prostate. 70: 735-44. PMID 20333727 DOI: 10.1002/Pros.21106 |
0.61 |
|
| 2010 |
Zeliadt SB, Ramsey SD, Van Den Eeden SK, Hamilton AS, Oakley-Girvan I, Penson DF, Fairweather ME, Arora NK, Potosky AL. Patient recruitment methods to evaluate treatment decision making for localized prostate cancer. American Journal of Clinical Oncology. 33: 381-6. PMID 20010079 DOI: 10.1097/Coc.0B013E3181B215D5 |
0.46 |
|
| 2009 |
Arora NK, Weaver KE, Clayman ML, Oakley-Girvan I, Potosky AL. Physicians' decision-making style and psychosocial outcomes among cancer survivors. Patient Education and Counseling. 77: 404-12. PMID 19892508 DOI: 10.1016/J.Pec.2009.10.004 |
0.359 |
|
| 2009 |
Haggstrom DA, Arora NK, Helft P, Clayman ML, Oakley-Girvan I. Follow-up care delivery among colorectal cancer survivors most often seen by primary and subspecialty care physicians. Journal of General Internal Medicine. 24: S472-9. PMID 19838853 DOI: 10.1007/S11606-009-1017-6 |
0.312 |
|
| 2009 |
Ramsey SD, Zeliadt SB, Arora NK, Potosky AL, Blough DK, Hamilton AS, Van Den Eeden SK, Oakley-Girvan I, Penson DF. Access to information sources and treatment considerations among men with local stage prostate cancer. Urology. 74: 509-15. PMID 19589564 DOI: 10.1016/J.Urology.2009.01.090 |
0.437 |
|
| 2009 |
Ramsey S, McDermott C, Zeliadt S, Blough D, Fedorenko C, Arora N, Penson D, Oakley-Girvan I, Hamilton A, Van Den Eeden S, Potosky A. PCN136 COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) USE AMONG LOCAL STAGE PROSTATE CANCER PATIENTS: TYPES, FACTORS ASSOCIATED WITH USE AND PERCEIVED BENEFITS Value in Health. 12: A283. DOI: 10.1016/S1098-3015(10)74386-2 |
0.473 |
|
| 2008 |
Zeliadt SB, Ramsey SD, Potosky AL, Arora NK, Blough DK, Oakley-Girvan I, Hamilton AS, Van Den Eeden SK, Penson DF. Association of Preexisting Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients. The Patient. 1: 189. PMID 20119493 DOI: 10.2165/1312067-200801030-00006 |
0.383 |
|
| 2008 |
Beckjord EB, Arora NK, McLaughlin W, Oakley-Girvan I, Hamilton AS, Hesse BW. Health-related information needs in a large and diverse sample of adult cancer survivors: implications for cancer care. Journal of Cancer Survivorship : Research and Practice. 2: 179-89. PMID 18792791 DOI: 10.1007/S11764-008-0055-0 |
0.386 |
|
| 2008 |
Borugian MJ, Spinelli JJ, Sun Z, Kolonel LN, Oakley-Girvan I, Pollak MD, Whittemore AS, Wu AH, Gallagher RP. Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a prospective multiethnic study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 252-4. PMID 18199733 DOI: 10.1158/1055-9965.Epi-07-2694 |
0.57 |
|
| 2008 |
Haggstrom D, Arora N, Oakley-Girvan I. Primary and subspecialty care models of follow-up care delivery among colorectal cancer survivors Journal of Clinical Oncology. 26: 6540-6540. DOI: 10.1200/Jco.2008.26.15_Suppl.6540 |
0.331 |
|
| 2007 |
Borugian MJ, Spinelli JJ, Sun Z, Kolonel LN, Oakley-Girvan I, Pollak MD, Whittemore AS, Wu AH, Gallagher RP. Prediagnostic C-peptide and risk of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2164-5. PMID 17932367 DOI: 10.1158/1055-9965.Epi-07-0495 |
0.59 |
|
| 2007 |
Ramus SJ, Harrington PA, Pye C, DiCioccio RA, Cox MJ, Garlinghouse-Jones K, Oakley-Girvan I, Jacobs IJ, Hardy RM, Whittemore AS, Ponder BA, Piver MS, Pharoah PD, Gayther SA. Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer. Human Mutation. 28: 1207-15. PMID 17688236 DOI: 10.1002/Humu.20599 |
0.597 |
|
| 2007 |
Camp NJ, Cannon-Albright LA, Farnham JM, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, ... ... Oakley-Girvan I, et al. Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Human Molecular Genetics. 16: 1271-8. PMID 17478474 DOI: 10.1093/Hmg/Ddm075 |
0.617 |
|
| 2007 |
Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, Neubauer J, Tandon A, Schirmer C, McDonald GJ, Greenway SC, Stram DO, Le Marchand L, Kolonel LN, Frasco M, ... ... Oakley-Girvan I, et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nature Genetics. 39: 638-44. PMID 17401364 DOI: 10.1038/Ng2015 |
0.667 |
|
| 2006 |
Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, Penney K, Steen RG, Ardlie K, John EM, Oakley-Girvan I, Whittemore AS, Cooney KA, Ingles SA, Altshuler D, et al. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proceedings of the National Academy of Sciences of the United States of America. 103: 14068-73. PMID 16945910 DOI: 10.1073/Pnas.0605832103 |
0.662 |
|
| 2006 |
Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, Thibodeau SN, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Badzioch M, ... ... Oakley-Girvan I, et al. Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Human Genetics. 120: 471-85. PMID 16932970 DOI: 10.1007/s00439-006-0219-9 |
0.649 |
|
| 2005 |
Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Bishop T, ... ... Oakley-Girvan I, et al. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. American Journal of Human Genetics. 77: 219-29. PMID 15988677 DOI: 10.1086/432377 |
0.626 |
|
| 2004 |
Whittemore AS, Balise RR, Pharoah PD, Dicioccio RA, Oakley-Girvan I, Ramus SJ, Daly M, Usinowicz MB, Garlinghouse-Jones K, Ponder BA, Buys S, Senie R, Andrulis I, John E, Hopper JL, et al. Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations. British Journal of Cancer. 91: 1911-5. PMID 15545966 DOI: 10.1038/Sj.Bjc.6602239 |
0.582 |
|
| 2004 |
Oakley-Girvan I, Feldman D, Eccleshall TR, Gallagher RP, Wu AH, Kolonel LN, Halpern J, Balise RR, West DW, Paffenbarger RS, Whittemore AS. Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 1325-30. PMID 15298953 |
0.574 |
|
| 2004 |
Werness BA, Ramus SJ, DiCioccio RA, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, Tsukada Y, Harrington P, Gayther SA, Ponder BA, Piver MS. Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 23: 29-34. PMID 14668547 DOI: 10.1097/01.Pgp.0000101083.35393.Cd |
0.588 |
|
| 2003 |
Oakley-Girvan I, Kolonel LN, Gallagher RP, Wu AH, Felberg A, Whittemore AS. Stage at diagnosis and survival in a multiethnic cohort of prostate cancer patients. American Journal of Public Health. 93: 1753-9. PMID 14534233 DOI: 10.2105/Ajph.93.10.1753 |
0.609 |
|
| 2002 |
Gong G, Oakley-Girvan I, Wu AH, Kolonel LN, John EM, West DW, Felberg A, Gallagher RP, Whittemore AS. Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada. Cancer Causes & Control : Ccc. 13: 471-82. PMID 12146852 DOI: 10.1023/A:1015755219674 |
0.654 |
|
| 2001 |
Hsieh CL, Oakley-Girvan I, Balise RR, Halpern J, Gallagher RP, Wu AH, Kolonel LN, O'Brien LE, Lin IG, Van Den Berg DJ, Teh CZ, West DW, Whittemore AS. A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity. American Journal of Human Genetics. 69: 148-58. PMID 11404817 DOI: 10.1086/321281 |
0.666 |
|
| 2000 |
Werness BA, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, Dicioccio RA, Tsukada Y, Ponder BA, Piver MS. Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations. Human Pathology. 31: 1420-4. PMID 11112219 DOI: 10.1016/S0046-8177(00)80014-3 |
0.572 |
|
| 2000 |
Werness BA, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Tsukada Y, Ponder BA, Piver MS. Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 19: 390-4. PMID 11109172 DOI: 10.1097/00004347-200010000-00017 |
0.61 |
|
| 2000 |
McGuire V, Whittemore AS, Norris R, Oakley-Girvan I. Survival in epithelial ovarian cancer patients with prior breast cancer. American Journal of Epidemiology. 152: 528-32. PMID 10997542 DOI: 10.1093/Aje/152.6.528 |
0.61 |
|
| 2000 |
Werness BA, Parvatiyar P, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Wiest J, Tsukada Y, Ponder BA, Piver MS. Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53. Journal of the National Cancer Institute. 92: 1088-91. PMID 10880552 DOI: 10.1093/Jnci/92.13.1088 |
0.55 |
|
| 1999 |
Whittemore AS, Lin IG, Oakley-Girvan I, Gallagher RP, Halpern J, Kolonel LN, Wu AH, Hsieh CL. No evidence of linkage for chromosome 1q42.2-43 in prostate cancer. American Journal of Human Genetics. 65: 254-6. PMID 10364541 DOI: 10.1086/302457 |
0.562 |
|
| 1999 |
Bosland MC, Oakley-Girvan I, Whittemore AS. Dietary fat, calories, and prostate cancer risk. Journal of the National Cancer Institute. 91: 489-91. PMID 10088612 DOI: 10.1093/Jnci/91.6.489 |
0.623 |
|
| 1997 |
Hsieh CL, Oakley-Girvan I, Gallagher RP, Wu AH, Kolonel LN, Teh CZ, Halpern J, West DW, Paffenbarger RS, Whittemore AS. Re: prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. Journal of the National Cancer Institute. 89: 1893-4. PMID 9414179 DOI: 10.1093/Jnci/89.24.1893 |
0.633 |
|
| 1995 |
Jishi MF, Itnyre JH, Oakley-Girvan IA, Piver MS, Whittemore AS. Risks of cancer among members of families in the Gilda Radner Familial Ovarian Cancer Registry. Cancer. 76: 1416-21. PMID 8620417 DOI: 10.1002/1097-0142(19951015)76:8<1416::Aid-Cncr2820760818>3.0.Co;2-D |
0.626 |
|
| Show low-probability matches. |